Company Valuation: Exosens

Data adjusted to current consolidation scope
Fiscal Period: December 2024 2025 2026 2027 2028
Market Cap 1 986.7 2,459 2,884 - -
Change - 149.26% 17.27% - -
Enterprise Value (EV) 1 1,131 2,657 3,040 2,976 2,897
Change - 134.98% 14.4% -2.1% -2.66%
P/E 31.9x 57.7x 36.6x 25.1x 21x
PBR 2.39x 5.51x 5.62x 4.78x 4.06x
PEG 0x 1.5x 0.4x 0.6x 1.1x
Capitalization / Revenue 2.5x 5.25x 5.15x 4.55x 4.03x
EV / Revenue 2.87x 5.68x 5.43x 4.7x 4.05x
EV / EBITDA 9.54x 17.5x 16.7x 14.2x 11.8x
EV / EBIT 11.9x 20.8x 20.2x 16.7x 14.2x
EV / FCF 20.4x 46.4x 49.5x 36.3x 26.8x
FCF Yield 4.9% 2.16% 2.02% 2.76% 3.73%
Dividend per Share 2 0.1 0.3 0.3797 0.519 0.6306
Rate of return 0.51% 0.62% 0.67% 0.92% 1.11%
EPS 2 0.61 0.84 1.55 2.254 2.694
Distribution rate 16.4% 35.7% 24.5% 23% 23.4%
Net sales 1 394.1 468.2 559.6 633.8 715.4
EBITDA 1 118.5 151.6 181.5 209.4 245.3
EBIT 1 95.3 127.6 150.7 178 204.7
Net income 1 30.7 42.7 80.03 113.6 134.9
Net Debt 1 144.1 197.7 155.7 91.73 12.71
Reference price 2 19.43 48.45 56.65 56.65 56.65
Nbr of stocks (in thousands) 50,783 50,762 50,911 - -
Announcement Date 03/03/25 23/02/26 - - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
35.1x6.49x27.21x0.59% 318B
30.56x2.86x16.99x1.55% 248B
25.44x1.69x12.57x1.81% 168B
34.86x5.08x21.31x0.98% 162B
33.03x3.62x16.42x1.25% 153B
-662.61x1.79x40.4x-.--% 152B
16.62x1.62x11.63x2.77% 117B
41.69x9.4x29.14x0.23% 91.55B
19.52x1.66x13.56x1.9% 89.61B
Average -47.31x 3.80x 21.03x 1.23% 166.65B
Weighted average by Cap. -39.80x 3.94x 21.57x 1.16%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Exosens

Historical PBR trend

Valuation ratios - PBR - Exosens

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Exosens

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Exosens


Year-on-year evolution of the Yield

Valuation ratios - Yield - Exosens